Autobio Diagnostics Co., Ltd. (SHA:603658)
36.20
+0.18 (0.50%)
At close: Dec 19, 2025
Autobio Diagnostics Revenue
Autobio Diagnostics had revenue of 1.07B CNY in the quarter ending September 30, 2025, a decrease of -9.04%. This brings the company's revenue in the last twelve months to 4.22B, down -7.92% year-over-year. In the year 2024, Autobio Diagnostics had annual revenue of 4.47B with 0.62% growth.
Revenue (ttm)
4.22B
Revenue Growth
-7.92%
P/S Ratio
4.90
Revenue / Employee
730.70K
Employees
5,773
Market Cap
20.69B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.47B | 27.55M | 0.62% |
| Dec 31, 2023 | 4.44B | 2.03M | 0.05% |
| Dec 31, 2022 | 4.44B | 675.71M | 17.94% |
| Dec 31, 2021 | 3.77B | 787.79M | 26.45% |
| Dec 31, 2020 | 2.98B | 298.70M | 11.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WuXi AppTec | 43.88B |
| Huadong Medicine | 43.09B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |
| Shanghai Fosun Pharmaceutical (Group) | 39.55B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| Zhejiang NHU Company | 22.47B |
| Aier Eye Hospital Group | 22.17B |